{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:02:50Z","timestamp":1780923770021,"version":"3.54.1"},"reference-count":32,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mirt"],"DOI":"10.4274\/mirt.galenos.2026.93764","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:26:38Z","timestamp":1773671198000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Value of 68Ga-FAPI PET\/CT Versus 18F-FDG PET\/CT in Laryngeal Cancer Staging"],"prefix":"10.4274","author":[{"given":"Ebuzer","family":"Kalender","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edanur Ekinci","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buket","family":"Eren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Elbo\u011fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertan","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","unstructured":"1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/jnci\/djn125","article-title":"18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis","volume":"100","author":"Kyzas","year":"2008","unstructured":"2. Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008;100:712-720.","journal-title":"J Natl Cancer Inst"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.oraloncology.2013.12.002","article-title":"A meta-analysis","volume":"50","author":"Gao","year":"2014","unstructured":"3. Gao S, Li S, Yang X, Tang Q. 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis. Oral Oncol. 2014;50:163-167.","journal-title":"Oral Oncol"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Yongkui L, Jian L, Wanghan, Jingui L. 18FDG-PET\/CT for the detection of regional nodal metastasis in patients with primary head and neck cancer before treatment: a meta-analysis. Surg Oncol. 2013;22:e11-e16.","DOI":"10.1016\/j.suronc.2013.02.002"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21386","article-title":"An update on larynx cancer","volume":"67","author":"Steuer","year":"2017","unstructured":"5. Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin. 2017;67:31-50.","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bjorl.2019.02.003","article-title":"Non-squamous cell carcinoma diseases of the larynx: clinical and imaging findings","volume":"86","author":"Do\u011fan","year":"2020","unstructured":"6. Do\u011fan S, Vural A, Kahriman G, \u0130mamo\u011flu H, Abd\u00fclrezzak \u00dc, \u00d6zt\u00fcrk M. Non-squamous cell carcinoma diseases of the larynx: clinical and imaging findings. Braz J Otorhinolaryngol. 2020;86:468-482.","journal-title":"Braz J Otorhinolaryngol"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Virtaniemi JA, Hirvikoski PP, Kumpulainen EJ, Johansson RT, Pukkala E, Kosma VM. Is the subsite distribution of laryngeal cancer related to smoking habits? Acta Oncol. 2000;39:77-79.","DOI":"10.1080\/028418600431012"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/oxfordjournals.epirev.a036223","article-title":"Epidemiology of laryngeal cancer","volume":"2","author":"Rothman","year":"1980","unstructured":"8. Rothman KJ, Cann CI, Flanders D, Fried MP. Epidemiology of laryngeal cancer. Epidemiol Rev. 1980;2:195-209.","journal-title":"Epidemiol Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1365-2796.2002.01022.x","article-title":"Tobacco use and cancer causation: association by tumour type","volume":"252","author":"Kuper","year":"2002","unstructured":"9. Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med. 2002;252:206-224.","journal-title":"J Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Department of Veterans Affairs Laryngeal Cancer Study Group; Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE, Endicott JW, McClatchey K, Henderson WG. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685-1690.","DOI":"10.1056\/NEJM199106133242402"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.2003.10.106","article-title":"Management and outcome differences in supraglottic cancer between Ontario, Canada, and the surveillance, epidemiology, and end results areas of the United States","volume":"21","author":"Groome","year":"2003","unstructured":"11. Groome PA, O'Sullivan B, Irish JC, Rothwell DM, Schulze K, Warde PR, Schneider KM, Mackenzie RG, Hodson DI, Hammond JA, Gulavita SP, Eapen LJ, Dixon PF, Bissett RJ, Mackillop WJ. Management and outcome differences in supraglottic cancer between Ontario, Canada, and the surveillance, epidemiology, and end results areas of the United States. J Clin Oncol. 2003;21:496-505.","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Becker M. Larynx and hypopharynx. Radiol Clin North Am. 1998;36:891-920, vi.","DOI":"10.1016\/S0033-8389(05)70068-3"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00405-008-0721-x","article-title":"Occult contralateral nodal metastases in supraglottic laryngeal cancer crossing the midline","volume":"266","author":"Ozt\u00fcrkcan","year":"2009","unstructured":"13. Ozt\u00fcrkcan S, Katilmi\u015f H, Ozdemir I, Tuna B, G\u00fcven\u00e7 IA, D\u00fcndar R. Occult contralateral nodal metastases in supraglottic laryngeal cancer crossing the midline. Eur Arch Otorhinolaryngol. 2009;266:117-120.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Kuno H, Onaya H, Fujii S, Ojiri H, Otani K, Satake M. Primary staging of laryngeal and hypopharyngeal cancer: CT, MR imaging and dual-energy CT. Eur J Radiol. 2014;83:e23-e35.","DOI":"10.1016\/j.ejrad.2013.10.022"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.otot.2024.04.004","article-title":"Imaging for larynx cancer assessment","volume":"35","author":"GJ","year":"2024","unstructured":"15. Mongelluzzo GJ, Fourgas EC. Imaging for larynx cancer assessment. Operative Techniques in Otolaryngology. 2024;35:141-148.","journal-title":"Operative Techniques in Otolaryngology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1148\/radiol.2492072183","article-title":"Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging","volume":"249","author":"Becker","year":"2008","unstructured":"16. Becker M, Zb\u00e4ren P, Casselman JW, Kohler R, Dulguerov P, Becker CD. Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging. Radiology. 2008;249:551-559.","journal-title":"Radiology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.nic.2008.01.001","article-title":"Perineural tumor spread","volume":"18","author":"Maroldi","year":"2008","unstructured":"17. Maroldi R, Farina D, Borghesi A, Marconi A, Gatti E. Perineural tumor spread. Neuroimaging Clin N Am. 2008;18:413-429.","journal-title":"Neuroimaging Clin N Am"},{"key":"ref17","unstructured":"18. Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW Jr, Pinto H, Kaplan MJ. Clinical role of 18F-FDG PET\/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med. 2007;48 Suppl 1:58S-67S."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/MLG.0b013e31805d017b","article-title":"Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography\/computed tomography on previously untreated head and neck cancer patients","volume":"117","author":"AJ Jr","year":"2007","unstructured":"19. Fleming AJ Jr, Smith SP Jr, Paul CM, Hall NC, Daly BT, Agrawal A, Schuller DE. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography\/computed tomography on previously untreated head and neck cancer patients. Laryngoscope. 2007;117:1173-1179.","journal-title":"Laryngoscope"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2214\/AJR.17.18301","article-title":"Clinical practice in PET\/CT for the management of head and neck squamous cell cancer","volume":"209","author":"Goel","year":"2017","unstructured":"20. Goel R, Moore W, Sumer B, Khan S, Sher D, Subramaniam RM. Clinical practice in PET\/CT for the management of head and neck squamous cell cancer. AJR Am J Roentgenol. 2017;209:289-303.","journal-title":"AJR Am J Roentgenol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.nic.2012.08.008","article-title":"Pitfalls in the staging of cancer of the laryngeal squamous cell carcinoma","volume":"23","author":"KL","year":"2013","unstructured":"21. Baugnon KL, Beitler JJ. Pitfalls in the staging of cancer of the laryngeal squamous cell carcinoma. Neuroimaging Clin N Am. 2013;23:81-105.","journal-title":"Neuroimaging Clin N Am"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejrad.2016.12.034","article-title":"Multiparametric evaluation by simultaneous PET-MRI examination in patients with histologically proven laryngeal cancer","volume":"88","author":"Cavaliere","year":"2017","unstructured":"22. Cavaliere C, Romeo V, Aiello M, Mesolella M, Iorio B, Barbuto L, Cantone E, Nicolai E, Covello M. Multiparametric evaluation by simultaneous PET-MRI examination in patients with histologically proven laryngeal cancer. Eur J Radiol. 2017;88:47-55.","journal-title":"Eur J Radiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","article-title":"Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy","volume":"8","author":"Hamson","year":"2014","unstructured":"23. Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteomics Clin Appl. 2014;8:454-463.","journal-title":"Proteomics Clin Appl"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A Tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","author":"Loktev","year":"2018","unstructured":"24. Loktev A, Lindner T, Mier W, Debus J, Altmann A, J\u00e4ger D, Giesel F, Kratochwil C, Barthe P, Roumestand C, Haberkorn U. A Tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59:1423-1429.","journal-title":"J Nucl Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","unstructured":"25. Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, Adeberg S, Rathke H, R\u00f6hrich M, Winter H, Plinkert PK, Marme F, Lang M, Kauczor HU, J\u00e4ger D, Debus J, Haberkorn U, Giesel FL. 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60:801-805.","journal-title":"J Nucl Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","article-title":"Cancer-associated fibroblasts in gastrointestinal cancer","volume":"16","author":"Kobayashi","year":"2019","unstructured":"26. Kobayashi H, Enomoto A, Woods SL, Burt AD, Takahashi M, Worthley DL. Cancer-associated fibroblasts in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2019;16:282-295.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","unstructured":"27. Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, Wei J, Wu S, Zhao L, Luo Z, Lin X, Xie C, Sun L, Lin Q, Wu H. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47:1820-1832.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","unstructured":"28. Giesel FL, Kratochwil C, Lindner T, Marschalek MM, Loktev A, Lehnert W, Debus J, J\u00e4ger D, Flechsig P, Altmann A, Mier W, Haberkorn U. 68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers. J Nucl Med. 2019;60:386-392.","journal-title":"J Nucl Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2967\/jnumed.119.237016","article-title":"The role of 68Ga-FAPI PET\/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience","volume":"61","author":"Koerber","year":"2020","unstructured":"29. Koerber SA, Staudinger F, Kratochwil C, Adeberg S, Haefner MF, Ungerechts G, Rathke H, Winter E, Lindner T, Syed M, Bhatti IA, Herfarth K, Choyke PL, Jaeger D, Haberkorn U, Debus J, Giesel FL. The role of 68Ga-FAPI PET\/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience. J Nucl Med. 2020;61:1331-1336.","journal-title":"J Nucl Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1007\/s00259-020-05095-0","article-title":"Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET\/CT versus MRI and [18F]-FDG PET\/CT","volume":"48","author":"Guo","year":"2021","unstructured":"30. Guo W, Pang Y, Yao L, Zhao L, Fan C, Ke J, Guo P, Hao B, Fu H, Xie C, Lin Q, Wu H, Sun L, Chen H. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET\/CT versus MRI and [18F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2021;48:1604-1617.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2967\/jnumed.121.262790","article-title":"The added value of 68Ga-FAPI PET\/CT in patients with head and neck cancer of unknown primary with 18F-FDG-negative findings","volume":"63","author":"Gu","year":"2022","unstructured":"31. Gu B, Xu X, Zhang J, Ou X, Xia Z, Guan Q, Hu S, Yang Z, Song S. The added value of 68Ga-FAPI PET\/CT in patients with head and neck cancer of unknown primary with 18F-FDG-negative findings. J Nucl Med. 2022;63:875-881.","journal-title":"J Nucl Med"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Bhat RR, Shivalingappa SS, Ashok M, Kesari A, Kedilaya S, L YU. Utilization of gallium-68 fibroblast activation protein inhibitor positron emission tomography (68Ga-FAPI PET) for head and neck malignancies with neck \u0131maging reporting and data system (Ni-RADS) correlation. Cureus. 2025;17:e78476.","DOI":"10.7759\/cureus.78476"}],"container-title":["Molecular Imaging and Radionuclide Therapy"],"original-title":[],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:17:27Z","timestamp":1780921047000},"score":1,"resource":{"primary":{"URL":"https:\/\/mirt.tsnmjournals.org\/articles\/diagnostic-value-of-lesssupgreater68lesssupgreaterga-fapi-petct-versus-lesssupgreater18lesssupgreaterf-fdg-petct-in-laryngeal-cancer-staging\/doi\/mirt.galenos.2026.93764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":32,"URL":"https:\/\/doi.org\/10.4274\/mirt.galenos.2026.93764","relation":{},"ISSN":["2146-1414","2147-1959"],"issn-type":[{"value":"2146-1414","type":"print"},{"value":"2147-1959","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}